These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16000684)

  • 21. Quetiapine for treatment-resistant delirium.
    Al-Samarrai S; Dunn J; Newmark T; Gupta S
    Psychosomatics; 2003; 44(4):350-1. PubMed ID: 12832605
    [No Abstract]   [Full Text] [Related]  

  • 22. Delirium associated with lithium-quetiapine combination.
    Miodownik C; Alkatnany A; Frolova K; Lerner V
    Clin Neuropharmacol; 2008; 31(3):176-9. PubMed ID: 18520985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V; Cañas F; Tafalla M;
    Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma.
    Farrell H; Eastman P
    BMJ Support Palliat Care; 2013 Mar; 3(1):4-5. PubMed ID: 24644317
    [No Abstract]   [Full Text] [Related]  

  • 25. Delirium caused by a drug-drug interaction between bupropion and risperidone.
    Lu YY; Hsueh JH; Wei IH; Huang CC
    J Clin Psychopharmacol; 2014 Feb; 34(1):161-2. PubMed ID: 24346746
    [No Abstract]   [Full Text] [Related]  

  • 26. A pilot trial of quetiapine for the treatment of patients with delirium.
    Pae CU; Lee SJ; Lee CU; Lee C; Paik IH
    Hum Psychopharmacol; 2004 Mar; 19(2):125-7. PubMed ID: 14994323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment.
    Bozina N; Jovanović N; Lovrić M; Medved V
    Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
    Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH
    Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone and quetiapine-related arthralgia.
    Wang TY; Tsai SJ
    J Clin Psychopharmacol; 2014 Apr; 34(2):271-2. PubMed ID: 24525656
    [No Abstract]   [Full Text] [Related]  

  • 30. Probable dementia with Lewy bodies and risperidone-induced delirium.
    Morikawa M; Kishimoto T
    Can J Psychiatry; 2002 Dec; 47(10):976. PubMed ID: 12553140
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A; Okamura T
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.
    Leon Jd; Susce MT; Pan RM; Wedlund PJ; Orrego ML; Diaz FJ
    Pharmacopsychiatry; 2007 May; 40(3):93-102. PubMed ID: 17541883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone- and quetiapine-induced cholestasis.
    Wright TM; Vandenberg AM
    Ann Pharmacother; 2007 Sep; 41(9):1518-23. PubMed ID: 17666578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine and delirium: lesson from clinical practice.
    Singh D; Forlano R
    Aust N Z J Psychiatry; 2008 May; 42(5):433-4. PubMed ID: 18499932
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver enzyme abnormalities during antipsychotic treatment: a case report of risperidone-associated hepatotoxicity.
    López-Torres E; Süveges A; Peñas-LLedó EM; Doña A; Dorado P; LLerena A; Berecz R
    Drug Metabol Drug Interact; 2014; 29(2):123-6. PubMed ID: 24598833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study.
    Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T
    Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient.
    Tei Y; Morita T; Inoue S; Miyata H
    Psychosomatics; 2004; 45(5):450-1. PubMed ID: 15345794
    [No Abstract]   [Full Text] [Related]  

  • 38. The association between cytochrome P450-2D6 genotype and prescription of antiparkinsonian drugs in hospitalized psychiatric patients using antipsychotics: a retrospective follow-up study.
    Mulder H; Wilmink FW; Belitser SV; Egberts AC
    J Clin Psychopharmacol; 2006 Apr; 26(2):212-5. PubMed ID: 16633157
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of delirium in older adults with quetiapine.
    Kim KY; Bader GM; Kotlyar V; Gropper D
    J Geriatr Psychiatry Neurol; 2003 Mar; 16(1):29-31. PubMed ID: 12641370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delirium in elderly patients treated with risperidone: a report of three cases.
    Ravona-Springer R; Dolberg OT; Hirschmann S; Grunhaus L
    J Clin Psychopharmacol; 1998 Apr; 18(2):171-2. PubMed ID: 9555603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.